Kestra Medical Technologies, Ltd. Common Stock Total Liabilities

Latest as of January 2026: $91.35 Million USD

Kestra Medical Technologies, Ltd. Common Stock total liabilities. Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has total liabilities worth $91.35 Million USD as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Kestra Medical Technologies, Ltd. Common to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Kestra Medical Technologies, Ltd. Common Stock (2020–2025)

Total liabilities of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's total liabilities have evolved over time, based on quarterly financial data.

Kestra Medical Technologies, Ltd. Common Stock Competitors by Total Liabilities

The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Capital Clean Energy Carriers Corp.
NASDAQ:CCEC
USA $2.60 Billion
Jungheinrich AG O.N.VZO
XETRA:JUN3
Germany €5.88 Billion
Sihui Fuji Electronics Technology Co Ltd
SHE:300852
China CN¥911.79 Million
Adriatic Metals Plc
F:3FN
Germany €192.27 Million
Ziel Home Furnishing Technology Co. Ltd. A
SHE:301376
China CN¥3.59 Billion
Cyrela Brazil Realty S.A. Empreendimentos e Participações
SA:CYRE3
Brazil R$13.46 Billion
Zhejiang Wanliyang Transmission Co Ltd
SHE:002434
China CN¥3.39 Billion
OSK Holdings Bhd
KLSE:5053
Malaysia RM5.43 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Kestra Medical Technologies, Ltd. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see KMTS current and non-current assets.

Liquidity & Leverage Metrics

Kestra Medical Technologies, Ltd. Common Stock Total Liabilities Ratios Explained

Kestra Medical Technologies, Ltd. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 7.32 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kestra Medical Technologies, Ltd. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)

The table below shows the annual total liabilities of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025.

Year Total Liabilities Change
2025-04-30 $90.34 Million -64.62%
2024-04-30 $255.33 Million +63.43%
2023-04-30 $156.23 Million +443.31%
2021-04-30 $28.76 Million +616.04%
2020-04-30 $4.02 Million --

About Kestra Medical Technologies, Ltd. Common Stock

NASDAQ:KMTS USA Medical Instruments & Supplies
Market Cap
$1.74 Billion
Market Cap Rank
#7774 Global
#2344 in USA
Share Price
$29.81
Change (1 day)
+0.40%
52-Week Range
$17.87 - $30.61
All Time High
$30.61
About

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more